From allusions in Alice in Wonderland to subject matter in Ted Talks, psychedelics are moving from pop culture parody toward mainstream medicine. What challenges does this evolution pose for the pharmaceutical community? Panelists will explore regulatory uncertainty, including psychedelics as a Schedule I drug and efficacy; patient safety data gaps; potential benefits of use; and cultural significance of psychedelics to many Indigenous people and the importance of those roots as psychedelics are developed for pharmaceutical purposes.
Robert Haferd, Restorative Justice Coordinator, Office of the Attorney General of the District of Columbia
Karen Luong, Litigation Attorney, Husch Blackwell LLP
Suzanne Sisley, Adjunct Professor, Humboldt Institute for Interdisciplinary Marijuana Research, California State Polytechnic University
Moderated by Deborah Miran, DMiran Consulting
|Student Member Price
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.